In an article published this December, Exame cites Biotecno as a reference in vaccine storage and transport, especially in logistics related to the imminent vaccination against Covid-19, alongside the largest global brands in the segment.
In the report, Roberto Olivares, Commercial Director at Biotecno, comments on the need for investment in the cold chain and talks about the company expansion plans:
“We have been in this market for twenty years and, in addition to Brazil, we are present in other countries in Latin America and we intend to expand to the Middle East soon, too. Certainly, we are prepared for any adversity that may arise halfway. Today, our cold chambers can withstand even a power failure of more than 72 hours. We have a big challenge ahead of us, but we are sure it will be worth it.”
Check the full article: